Live Breaking News & Updates on Brian Strem

Stay updated with breaking news from Brian strem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences

Kiora Pharmaceuticals, Inc. , will participate in two upcoming investor conferences that will be available to investors live with the replay available on-demand. On Wednesday May 22, at 3:00 pm. ....

Brian Strem , California Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , Wednesday May , Eastern Time , Executive Vice President , Melissa Tosca , Webull Corporate Connect Biotech Investment , Lytham Partners Spring , Lytham Partners ,

Kiora, Théa Open Innovation enter agreement for inherited retinal disease treatment

Kiora, Théa Open Innovation enter agreement for inherited retinal disease treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Brian Strem , Kiora Pharmaceuticals , Open Innovation ,

Kiora Pharmaceuticals (KPRX) and Thea Open Innovation Enter Agreement to Develop and Commercialize KIO-301

Kiora Pharmaceuticals (KPRX) and Thea Open Innovation Enter Agreement to Develop and Commercialize KIO-301
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Brian Strem , Kiora Pharmaceuticals Inc , American Academy Of Ophthalmology , Kiora Pharmaceuticals , Open Innovation , Retinitis Pigmentosa , American Academy , Retinal Ganglion Cells , Investor Relations ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Clermont Ferrand , Brian Strem , Stefan Klotter , France Newsfile Corp , Kiora Pharmaceuticals , Kiora Pharmaceuticals Inc , American Academy Of Ophthalmology , Open Innovation , Retinitis Pigmentosa , American Academy , Retinal Ganglion Cells , Investor Relations , North Africa , South America , Private Securities Litigation Reform Act , Annual Report , Die Performance Strategie , Assets Sie ,